Director
DIN: 03344637
Gandavarapu Sharma is currently associated with 3 companies in various capacities such as Director and Designated Partner. They serve as a Director at REICHINDIA PHARMA LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 03344637.Gandavarapu Sharma has previously been associated with 2 companies in roles such as Additional Director.Gandavarapu Sharma is currently involved in 2 different roles. Their most recent position is with DEPTH ASSOCIATES LLP as a Designated Partner. The first company Gandavarapu Sharma was appointed to as a director was REICHINDIA PHARMA LIMITED. Gandavarapu Sharma is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Gandavarapu Sharma is currently associated with 3 companies in various capacities such as Director and Designated Partner. They serve as a Director at REICHINDIA PHARMA LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 03344637.Gandavarapu Sharma has previously been associated with 2 companies in roles such as Additional Director.Gandavarapu Sharma is currently involved in 2 different roles. Their most recent position is with DEPTH ASSOCIATES LLP as a Designated Partner. The first company Gandavarapu Sharma was appointed to as a director was REICHINDIA PHARMA LIMITED. Gandavarapu Sharma is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (2)
Current LLPs (1)
Past Companies (2)
2y 9m 1y 5m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| REICHINDIA PHARMA LIMITED | Director | 30-Sep-2013 |
| REICHINDIA BIO - APPLICATIONS LIMITED | Director | 29-Sep-2018 |